Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement.

被引：0
|
作者：
Pladevall, M. [1 ]
Williams, K. L. [1 ]
Lafata, J. Elston [1 ]
Tunceli, K. [1 ]
Wang, M. [1 ]
Campbell, I. [1 ]
Divine, G. [1 ]
Yang, J. [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2007年 / 165卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] LDL-cholesterol goal attainment among patients treated with lipid lowering drugs in Spain
    García-Ruiz, FJ
    Marín, A
    Pérez-Jimenez, F
    Pintó, X
    Nocea, G
    Casado, MA
    Erbey, J
    Alemao, EA
    Yi, DD
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 119 - 119
  • [2] Lipid-lowering therapies and achievement of LDL-cholesterol targets
    Rizzo, Manfredi
    Banach, Maciej
    Montalto, Giuseppe
    Mikhailidis, Dimitri P.
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) : 598 - 600
  • [3] NEW DRUGS FOR LOWERING LDL-CHOLESTEROL
    Badescu, Codruta
    Rezus, Elena
    Badescu, L.
    Dima, Nicoleta
    Rezus, C.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (03): : 485 - 490
  • [4] Adherence to Statins and LDL-Cholesterol Goal Attainment
    Chi, Margaret D.
    Vansomphone, Southida S.
    Liu, In-Lu Amy
    Cheetham, T. Craig
    Green, Kelley R.
    Scott, Ronald D.
    Reynolds, Kristi
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (04): : E105 - E112
  • [5] Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy
    Laforest, Laurent
    Moulin, Philippe
    Souchet, Thierry
    Ritleng, Cecile
    Desamericq, Gaelle
    Le Jeunne, Philippe
    Schwalm, Marie-Sophie
    Kieffer, Alexia
    Van Ganse, Eric
    ATHEROSCLEROSIS, 2008, 199 (02) : 368 - 377
  • [6] INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E301
  • [7] Update on lipid-lowering therapy and LDL-cholesterol targets
    Stephen D Wiviott
    Christopher P Cannon
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 424 - 436
  • [8] Update on lipid-lowering therapy and LDL-cholesterol targets
    Wiviott, Stephen D.
    Cannon, Christopher P.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (08): : 424 - 436
  • [9] GENETIC DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND LDL-CHOLESTEROL GOAL ACHIEVEMENT
    Alonso, R.
    Villar, J.
    Fuentes, F.
    Zambon, D.
    Mata, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] ACHIEVEMENT OF THE TARGET GOAL FOR LDL-CHOLESTEROL BY ROSUVASTATIN IN JAPANESE HYPERCHOLESTEROLEMIC SUBJECTS
    Nakano, S.
    Yoshino, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 185 - 185
12345